Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner
✍ Scribed by Takayuki Hattori; Kyoko Kitagawa; Chiharu Uchida; Toshiaki Oda; Masatoshi Kitagawa
- Book ID
- 104460523
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 273 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1356-9597
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background: Recent work has demonstrated the role of cdc kinase subunit 1 (Cks1) in the ubiquitin‐proteasome dependent degradation of CDK inhibitor p27^Kip1^ protein as an essential cofactor for SCF^Skp2^ ubiquitin ligase. Although over‐expression of Cks1 protein as well as it of Skp2 might be associated with tumour progression via p27^Kip1^ protein degradation, it is unknown how the cellular level of Cks1 is regulated.
Results: Here we show that Cks1 protein is degraded via the ubiquitin‐proteasome pathway. Degradation of Cks1 protein was markedly inhibited by proteasome inhibitors. In addition, Cks1 protein was modified with polyubiquitin chains both in vivo and in vitro. Furthermore, we found that degradation of Cks1 protein via the ubiquitin‐proteasome pathway was facilitated in M phase during the cell cycle.
Conclusion: These observations suggest that the level of expression of Cks1 protein is regulated at not only the transcriptional level but also the post‐translational level via the ubiquitin‐proteasome pathway in a cell‐cycle‐dependent manner.
📜 SIMILAR VOLUMES
In animals, MAP kinase plays a key role in growth factor‐stimulated signalling and in mitosis. The isolation of a __Medicago sativa__ cDNA clone __MsK7__ which shows 52% identity to animal MAP kinases is reported. The deduced protein sequence shows all the important structural features of MAP kinase
## Abstract Previous work showed a genetic control of cell cycle deregulation during hepatocarcinogenesis. We now evaluated in preneoplastic lesions, dysplastic nodules and hepatocellular carcinoma (HCC), chemically induced in genetically susceptible F344 and resistant Brown Norway (BN) rats, the r